Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs" under the "false guise" of personalization.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
HIMS
since
auto-detected in 35 stories
5 months ago
page 1 of 1